Clinical trial
Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in…
NCT00050180 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00050180 |
|---|---|
| Title | Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers |
| Official title | Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy, HIV Infections |
| Intervention type | Drug |
| Interventions | Midazolam, Indinavir, Saquinavir |
| Enrollment | 81 |
| Start date | Nov 22, 2002 |
| Primary completion | Aug 24, 2007 |
| Completion | Aug 24, 2007 |
| First posted | Nov 26, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: